Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

790 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [177Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside.
Arbuznikova D, Klotsotyra A, Uhlmann L, Domogalla LC, Steinacker N, Mix M, Niedermann G, Spohn SKB, Freitag MT, Grosu AL, Meyer PT, Gratzke C, Eder M, Zamboglou C, Eder AC. Arbuznikova D, et al. Among authors: eder m, eder ac. Theranostics. 2024 Apr 8;14(6):2560-2572. doi: 10.7150/thno.93249. eCollection 2024. Theranostics. 2024. PMID: 38646643 Free PMC article.
Development and Preclinical Evaluation of [211At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate Cancer.
El Fakiri M, Ayada N, Müller M, Hvass L, Gamzov TH, Clausen AS, Geis NM, Steinacker N, Hansson E, Lindegren S, Aneheim E, Jensen H, Eder AC, Jensen AI, Poulie CBM, Kjaer A, Eder M, Herth MM. El Fakiri M, et al. Among authors: eder m, eder ac. J Nucl Med. 2024 Apr 1;65(4):593-599. doi: 10.2967/jnumed.123.267043. J Nucl Med. 2024. PMID: 38423784
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party.
Duque-Afonso J, Finke J, Ngoya M, Galimard JE, Schetelig J, Eder M, Rösler W, Bug G, Neubauer A, Edinger M, Wulf GG, Jindra P, Einsele H, Stelljes M, Selleslag D, Wagner-Drouet EM, Bunjes D, Spyridonidis A, Brissot E, Nagler A, Ciceri F, Mohty M. Duque-Afonso J, et al. Among authors: eder m. Bone Marrow Transplant. 2024 Dec 19. doi: 10.1038/s41409-024-02499-6. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39702670
Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party.
Brijs J, Peczynski C, Boreland W, Cuoghi A, Maertens J, Mohty M, Kröger N, Nakov P, Broers AEC, Eder M, Herrera Arroyo C, Kaufmann M, Ram R, Schaap NPM, Graham C, Mussetti A, Penack O, Moiseev I, Peric Z, Schoemans H. Brijs J, et al. Among authors: eder m. Bone Marrow Transplant. 2024 Dec 13. doi: 10.1038/s41409-024-02497-8. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39668190 No abstract available.
Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell Therapy.
Bethge W, Flossdorf S, Hanke F, Schmid C, Ringhoffer M, Klein S, Hertenstein B, Schetelig J, Stelljes M, Schroeder T, Blau IW, Ayuk F, Eder M, Zeiser R, Fleischhauer K, Kröger N, Dreger P. Bethge W, et al. Among authors: eder m. Haematologica. 2024 Dec 5. doi: 10.3324/haematol.2024.286385. Online ahead of print. Haematologica. 2024. PMID: 39633549 Free article.
Methotrexate Versus Mycophenolate Mofetil Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Malignancies: A Retrospective Analysis on Behalf of the Chronic Malignancies Working Party of the EBMT.
Luft T, Gras L, Koster L, Kröger N, Schröder T, Platzbecker U, Sockel K, de Latour RP, Stelljes M, Sengeloev H, Eder M, Blau IW, Dreger P, Yakoub-Agha I, Maertens J, Salmenniemi U, Bethge W, Mielke S, Kobbe G, Pouli A, de Wreede LC, Raj K, Drozd-Sokolowska J, McLornan DP, Robin M. Luft T, et al. Among authors: eder m. Am J Hematol. 2025 Jan;100(1):38-51. doi: 10.1002/ajh.27531. Epub 2024 Nov 28. Am J Hematol. 2025. PMID: 39605194
790 results